Conversion surgery after gemcitabine and cisplatin plus durvalumab for advanced intrahepatic cholangiocarcinoma: A case report

Figure 1 Dynamic computed tomography before and after eight courses of gemcitabine and cisplatin plus durvalumab. A: Advanced intrahepatic cholangiocarcinoma at the left hepatic duct; B: Tumor invasion of the umbilical portion of the portal vein; C: Suspected direct invasion of the extrahepatic bile duct. Bile duct wall enhancement continuous from the tumor extended to the anterior and posterior sectoral duct; D: Tumor showing remarkable shrinkage; E: Amelioration of the dilation of the intrahepatic bile duct; F: Bile duct wall enhancement showing significant decrease at the anterior and posterior sectoral duct. Yellow arrows indicate the following findings.